In recent years, therapeutic antibodies have become the predominant class of new drugs developed in order to combat different diseases including cancers and autoimmune diseases among others. Antibody drug discovery does not come without its challenges including screening, characterization and target identification.
- Target discovery
- Lead generation, identification and optimization
Preclinical testing - FDA guidance for the industry
